The triple test

Clinical Chemistry

Volumn 60, Issue 1, 2014, Pages 269-270

  Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; DNA; ESTRIOL;

AMNIOCENTESIS; DOWN SYNDROME; FALSE POSITIVE RESULT; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MATERNAL SERUM SCREENING TEST; NEURAL TUBE DEFECT; NOTE; PREGNANT WOMAN; PRENATAL CARE; PRENATAL SCREENING;

EID: 84891757374     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.212050     Document Type: Note

References (4)

1. Wald NJ. The detection of neural tube defects by screening maternal blood. In: Boué A, ed. Prenatal diagnosis. Paris: Colloques de INSERM 1976;61: 227-38.
2. Wald NJ, Cuckle H, Brock DJH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of the UK Collaborative Study on Alpha-Fetoprotein in Relation to Neural-Tube Defects. Lancet 1977;1: 1323-32. (Pubitemid 8127680)
3. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984;1: 926-9. (Pubitemid 14136296)
4. Wald NJ, Bestwick J, Huttly W. Improvements in antenatal screening for Down's syndrome. J Med Screen 2013;20: 7-14.